Despite resumption of in-person screenings, catching up from COVID-19 disruptions will be difficult
Should Changes Made to Clinical Trials During Pandemic Be Kept?
Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19
Remote Monitoring System Reduces Chemotherapy Symptom Burden
Significant reductions seen for global distress index, psychological symptoms, physical symptoms of Memorial Symptom Assessment Scale
Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19
Lower 30-day mortality seen in hospitalized adults, including those admitted to ICU, requiring mechanical ventilation
SARS-CoV-2 Mortality Up for Patients With Active Cancer
No link found for cancer-directed medical therapy with death; highest mortality rate seen for patients with hematologic malignancy
Many Oncology Patients Are Lonely During COVID-19
Those categorized as lonely have higher levels of social isolation, higher symptom severity scores for all symptoms
COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively